Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Schistosoma haematobium in Urine Cytology: Diagnosis Is Possible.
Bellafiore S, Zanichelli M, Piana S. Bellafiore S, et al. Among authors: zanichelli m. Am J Med. 2018 Mar;131(3):e87-e88. doi: 10.1016/j.amjmed.2017.09.041. Epub 2017 Oct 12. Am J Med. 2018. PMID: 29032230 No abstract available.
Contrast-enhanced ultrasound appearance of primary epiploic appendagitis.
Menozzi G, Maccabruni V, Zanichelli M, Massari M. Menozzi G, et al. Among authors: zanichelli m. J Ultrasound. 2014 Feb 14;17(1):75-6. doi: 10.1007/s40477-014-0073-x. eCollection 2014 Mar. J Ultrasound. 2014. PMID: 24616754 Free PMC article. No abstract available.
Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis.
Kantarjian HM, Hughes TP, Larson RA, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Boquimpani C, Pasquini R, Clark RE, Dubruille V, Flinn IW, Kyrcz-Krzemien S, Medras E, Zanichelli M, Bendit I, Cacciatore S, Titorenko K, Aimone P, Saglio G, Hochhaus A. Kantarjian HM, et al. Among authors: zanichelli m. Leukemia. 2021 Jul;35(7):2142-2143. doi: 10.1038/s41375-021-01306-1. Leukemia. 2021. PMID: 34108614 Free PMC article. No abstract available.
Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis.
Kantarjian HM, Hughes TP, Larson RA, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Boquimpani C, Pasquini R, Clark RE, Dubruille V, Flinn IW, Kyrcz-Krzemien S, Medras E, Zanichelli M, Bendit I, Cacciatore S, Titorenko K, Aimone P, Saglio G, Hochhaus A. Kantarjian HM, et al. Among authors: zanichelli m. Leukemia. 2021 Feb;35(2):440-453. doi: 10.1038/s41375-020-01111-2. Epub 2021 Jan 7. Leukemia. 2021. PMID: 33414482 Free PMC article. Clinical Trial.
BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy.
Pereira WO, De Carvalho DD, Zenteno ME, Ribeiro BF, Jacysyn JF, Sardinha LR, Zanichelli MA, Hamerschlak N, Jones GE, Pagnano KB, Castro FA, Calle Y, Amarante-Mendes GP. Pereira WO, et al. Among authors: zanichelli ma. Cell Death Dis. 2017 Oct 12;8(10):e3114. doi: 10.1038/cddis.2017.458. Cell Death Dis. 2017. PMID: 29022901 Free PMC article.
31 results